Previous studies have attributed the protective effects of galectin-3 in diabetes and atherosclerosis to an indirect role in the removal of AGEs from circulation, thereby preventing subsequent tissue damage and activation of the pro-inflammatory RAGE-pathway [14, 39]. Here, LGALS3 is linked to atherosclerosis.